DEPARTMENT OF PHARMACOLOGY
CALCIUM METABOLISM
Introduction
Calcium metabolism involves the regulation of calcium levels in the blood and
bones, crucial for bone health, nerve transmission, muscle contraction, and
blood clotting. The body maintains calcium balance through the coordinated
action of hormones like parathyroid hormone, calcitonin, and vitamin D, which
influence calcium absorption, excretion, and storage.
Classification of drugs affecting calcium metabolism
Mechanism of Action of Drugs Affecting Calcium Metabolism
1. Bisphosphonates
(e.g. Alendronate, Zoledronate, Risedronate)
Bind to bone surfaces and are taken up by osteoclasts.
Inhibit osteoclast activity by:
● Disrupting the ruffled border of osteoclasts.
● Promoting osteoclast apoptosis
● Blocking the mevalonate pathway needed for osteoclast function
(important for alendronate, risedronate)
2. Vitamin D (Calcitriol and Analogues)
● Increase plasma calcium and phosphate by:
○ Enhancing intestinal absorption of calcium and phosphate.
○ Increasing renal tubular reabsorption.
● Promoting bone resorption to release calcium and phosphate
3. Parathyroid Hormone (PTH, Teriparatide)
● Acts on PTH receptors (G-protein coupled) → activates
adenylyl cyclase → ↑ cAMP → cellular effects:
○ ↑ Bone resorption (in continuous doses).
○ ↑ Renal reabsorption of calcium.
○ ↓ Renal reabsorption of phosphate.
○ Stimulates calcitriol synthesis, enhancing GI calcium absorption
4. Calcitonin
● Synthesized by thyroid C-cells; opposed PTH.
● Lowers plasma calcium and phosphate by:
○ Inhibiting osteoclasts → ↓ bone resorption.
○ Reducing renal tubular reabsorption of calcium and phosphate
5. Cinacalcet (Calcimimetic Agent)
● Binds to calcium-sensing receptors on parathyroid gland.
● Suppresses PTH secretion → ↓ serum calcium level
6. Glucocorticoids
● Decrease calcium absorption from the gut.
● Increase renal excretion of calcium
Promote osteoblast inhibition and osteoclast activation, leading to bone
loss/osteoporosis
Therapeutic Indications of Calcium Metabolism Drugs
Drug/Class Therapeutic Indications
Calcium Salts - Calcium deficiency (growth, pregnancy,
osteoporosis, rickets) - Tetany - Antacid
- Urticaria/dermatoses
Vitamin D & Analogues - Nutritional rickets/osteomalacia - Renal
rickets - Hypoparathyroidism - Vitamin
D–dependent/resistant rickets -
Osteoporosis - Psoriasis (Calcipotriol)
Bisphosphonates - Paget’s disease - Postmenopausal and
corticosteroid-induced osteoporosis -
Hypercalcaemia of malignancy -
Hyperparathyroidism-associated
hypercalcaemia - Painful lytic bone
lesions
Calcitonin - Hypercalcaemia (e.g., in malignancy) -
Paget’s disease - Osteoporosis
(postmenopausal, corticosteroid-induced)
Teriparatide (PTH analogue) - Severe osteoporosis (especially in
postmenopausal women)
Cinacalcet (Calcimimetic) - Hypercalcaemia due to parathyroid
tumour - Secondary hyperparathyroidism
due to chronic kidney disease
Glucocorticoids - Used in vitamin D toxicity to reduce
serum calcium - Long-term use may
cause
Adverse Effects of Calcium Metabolism Drugs
Drug/Class Adverse Effects
Calcium Salts - Constipation - Hypercalcaemia with
high doses - IV calcium chloride may
cause tissue necrosis
Vitamin D - Hypercalcaemia (nausea, fatigue,
weakness, polyuria) - Renal stones -
Renal failure with prolonged overdose
Bisphosphonates - Esophagitis (oral forms) -
Abdominal pain, nausea -
Osteonecrosis of jaw (rare, serious) -
Hypocalcaemia
Teriparatide (PTH analogue) - Hypercalcaemia - Expensive
therapy
Calcitonin - Nausea, vomiting - Flushing - Pain
at injection site - Antibody formation
with porcine source
Cinacalcet (Calcimimetic)
- Hypocalcemia
BISPHOSPHONATES
Introduction
Bisphosphonates are a class of drugs that prevent bone resorption by inhibiting
osteoclast activity. They are primarily used in the management of osteoporosis,
Paget’s disease, and hypercalcemia of malignancy. Their mechanism of action
varies depending on the chemical structure—nitrogenous and non-nitrogenous
subtypes.
Classification of Bisphosphonates
Mechanism of Action of Bisphosphonates
Non-nitrogen bisphosphonates:
Incorporated into ATP analogs, causing osteoclast apoptosis.
Nitrogen bisphosphonates:
Inhibit farnesyl pyrophosphate synthase in the mevalonate
pathway → inhibits osteoclast function and promotes
apoptosis
Therapeutic Indications of Bisphosphonates
Condition Drug Example
Postmenopausal osteoporosis Alendronate, Risedronate
Paget’s disease of bone Etidronate, Zoledronate
Hypercalcemia of malignancy Zoledronate
Osteolytic bone metastases Clodronate, Zoledronate
Glucocorticoid-induced osteoporosis Alendronate
Adverse Effects of Bisphosphonates
● GI effects: Esophagitis, gastritis (oral forms)
● Musculoskeletal pain
● Hypocalcemia
● Osteonecrosis of the jaw (rare, more common with IV forms)
● Atypical femur fractures (with long-term use)
ANTIDIURETICS
Introduction
Antidiuretics, also known as antidiuretic hormones or ADH analogues, regulate
the body’s water balance by controlling the amount of water reabsorbed in the
kidneys. These agents are used in conditions such as diabetes insipidus and
nocturnal enuresis and work by acting on specific receptors in the renal tubules.
Classification of Antidiuretics
Class Drugs
Natural hormone Vasopressin (ADH)
Synthetic analogues Desmopressin (DDAVP)
Vasopressin receptor agonists Terlipressin, Lypressin
ADH secretion stimulants Chlorpropamide, Carbamazepine
ADH degradation inhibitors Clofibrate
Mechanism of Action of Antidiuretics
● Vasopressin (ADH) acts on V2 receptors in renal collecting
ducts
→ ↑ insertion of aquaporin-2 water channels
→ ↑ water reabsorption → ↓ urine output
● Desmopressin: Selective V2 agonist (longer acting, minimal V1 effect)
● Terlipressin: Acts on V1 receptors → vasoconstriction
(used in bleeding esophageal varices
Therapeutic Indications of Antidiuretics
Drug/Class Therapeutic Indications
Desmopressin Central diabetes insipidus, nocturnal
enuresis, von Willebrand disease
Vasopressin Vasodilatory shock (e.g., septic
shock), GI bleeding
Terlipressin Bleeding esophageal varices,
hepatorenal syndrome
Chlorpropamide Mild diabetes insipidus (rare use)
Adverse Effects of Antidiuretics
● Water intoxication → hyponatremia
● Headache, nausea, abdominal cramps
● Vasopressin: Vasoconstriction → hypertension, angina,
arrhythmia
● Desmopressin: Seizures (due to hyponatremia in children)
● Terlipressin: Ischemia due to vasoconstriction
SUPERINFECTIONS
Introduction
Superinfections occur when normal microbial flora is disrupted, often due to
prolonged or broad-spectrum antibiotic use, leading to the overgrowth of
opportunistic pathogens. These infections are challenging to treat and often
require additional or alternative antimicrobial therapy.
Example:
Pseudomembranous colitis
Candidiasis
Enterococcal infection
Mechanism of Action of Superinfections
● Disruption of normal microbial flora (especially in the gut and mucosa).
● Overgrowth of resistant or opportunistic pathogens.
● Reduced immune defense (especially with immunosuppressants).
Therapeutic Indications of Superinfections
Drug/Class Therapeutic Indications
Vancomycin (oral) Clostridioides difficile infection (first-
line in severe cases)
Fidaxomicin Recurrent or severe C. difficile
infections
Metronidazole Mild to moderate C. difficile colitis
Fluconazole, Nystatin Oral/vaginal candidiasis
Amphotericin B, Caspofungin Systemic fungal infections
Linezolid, Daptomycin MRSA or VRE infections
Adverse Effects of Superinfections
● Vancomycin: Nephrotoxicity, ototoxicity (rare with oral form)
● Metronidazole: Metallic taste, GI upset, disulfiram-like reaction
● Fluconazole: Liver enzyme elevation, QT prolongation
● Amphotericin B: Nephrotoxicity, electrolyte imbalance
● Linezolid: Myelosuppression, neuropathy with long-term use
ANDROGENS AND RELATED DRUGS
Introduction
Androgens are male sex hormones responsible for the development and
maintenance of male characteristics. Drugs affecting androgen pathways
include anabolic steroids, anti-androgens, and hormone analogues, used in a
variety of conditions ranging from hypogonadism to prostate cancer and
androgenic alopecia.
Classification of Androgens and related drugs
0
Mechanism of Action of Androgens and Related drugs
● Testosterone binds to androgen receptors → regulates
gene expression → promotes male sexual development,
muscle growth.
● Anabolic steroids enhance protein synthesis → increased
muscle mass
● Anti-androgens block androgen receptors → inhibit
androgen action (e.g., in prostate cancer)
● 5α-reductase inhibitors prevent conversion of testosterone
to dihydrotestosterone (DHT) → useful in BPH, androgenic
alopecia
● GnRH analogues/antagonists suppress LH and FSH
secretion → ↓ testosterone production
Therapeutic Indications of Androgens and related drugs
Drug/Class Therapeutic Indications
Testosterone
Hypogonadism, delayed puberty, male
hormone replacement
Nandrolone Anemia, wasting syndromes,
osteoporosis
Finasteride Benign prostatic hyperplasia, male
pattern baldness
Flutamide, Bicalutamide Prostate cancer
Leuprolide Prostate cancer, precocious puberty,
endometriosis
Adverse Effects of Androgens and related drugs
● Androgens: Acne, virilization in females, premature epiphyseal closure
in children, hepatotoxicity
● Anabolic steroids: Aggression, gynecomastia, testicular atrophy,
infertility
● Anti-androgens: Gynecomastia, liver dysfunction
● 5α-reductase inhibitors: Impotence, ↓ libido
● GnRH analogues: Hot flashes, decreased bone density (with long-term
use)
FIXED DOSE COMBINATIONS (FDCs)
Introduction
Fixed Dose Combinations (FDCs) are pharmaceutical products that contain two
or more active drugs in a single dosage form. FDCs are commonly used to
improve patient compliance, reduce pill burden, and enhance therapeutic
outcomes in conditions like hypertension, diabetes, tuberculosis, and HIV.
FIXED-DOSE COMBINATIONS EXAMPLES
Trimethoprim + Sulfamethoxazole
Amoxicillin + Clavulanic Acid
Glimepiride + Metformin
Amlodipine + Atenolol
Fluticasone + Salmeterol
Artemether + Lumefantrine
Lopinavir + Ritonavir
Mechanism of Action of Fixed Dose Combinations (FDCs)
FDCs act through multiple mechanisms depending on the combination, e.g.:
● Amoxicillin + Clavulanic acid
o Amoxicillin: inhibits bacterial cell wall synthesis
o Clavulanic acid: inhibits β-lactamase enzyme →
prevents degradation of amoxicillin
● Glimepiride + Metformin
o Glimepiride: increases insulin release
o Metformin: decreases hepatic glucose production and increases
insulin sensitivity
Adverse Effects of Fixed Dose Combinations (FDCs)
● Dose inflexibility: Cannot titrate individual components
● Increased risk of adverse effects due to drug interactions
● Inappropriate combinations (e.g., irrational FDCs found in market)
● Overuse can lead to resistance, especially in antimicrobials